Nick Pizzie - Feb 13, 2025 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Chief Financial Officer
Signature
/s/ Nick Pizzie
Stock symbol
AXSM
Transactions as of
Feb 13, 2025
Transactions value $
-$1,951,530
Form type
4
Date filed
2/14/2025, 09:20 PM
Previous filing
Feb 29, 2024
Next filing
Feb 25, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXSM Common Stock Options Exercise $42K +12K +28.44% $3.50 54.2K Feb 13, 2025 Direct F1, F2
transaction AXSM Common Stock Sale -$1.56M -12K -22.15% $129.86 42.2K Feb 13, 2025 Direct F2, F3, F4
transaction AXSM Common Stock Options Exercise $10.5K +3K +7.11% $3.50 45.2K Feb 14, 2025 Direct F1, F2
transaction AXSM Common Stock Sale -$393K -3K -6.64% $131.07 42.2K Feb 14, 2025 Direct F2, F3, F5
holding AXSM Common Stock 488 Feb 13, 2025 See explanation 6 below. F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Options Exercise -$42K -12K -100% $3.50 0 Feb 13, 2025 Common Stock 12K $3.50 Direct F1, F2
transaction AXSM Stock Option (Right to Buy) Options Exercise -$10.5K -3K -100% $3.50 0 Feb 14, 2025 Common Stock 3K $3.50 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents an exercise of stock options which was held for 7 years and exercised prior to the 10 year expiration date of such options.
F2 Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed.
F3 Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
F4 Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $128.50 and $131.64.
F5 Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $130.06 and $131.72.
F6 Represents additional shares indirectly beneficially owned by the reporting person as custodian for his children's UTMA accounts.